Extended-Release Buprenorphine During Pregnancy and the First Year After Birth—Protecting Pregnant People Through Ethical Research
JAMA Internal Medicine · 01.05.2026 · 186 (5) · 544
DOI: 10.1001/jamainternmed.2026.0068 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Internal Medicine, erschienen am 01.05.2026. Verfasst von Mishka Terplan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Friends Research Institute, Baltimore, Maryland. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Friends Research Institute, Baltimore, Maryland.
- University of North Carolina, Chapel Hill.
Zitieren
APA
Terplan, M., Lyerly, A. D., & Jones, H. (2026). Extended-Release Buprenorphine During Pregnancy and the First Year After Birth—Protecting Pregnant People Through Ethical Research. JAMA Internal Medicine, 186(5), 544. https://doi.org/10.1001/jamainternmed.2026.0068
Vancouver
Terplan M, Lyerly AD, Jones H. Extended-Release Buprenorphine During Pregnancy and the First Year After Birth—Protecting Pregnant People Through Ethical Research. JAMA Internal Medicine. 2026;186(5):544. doi:10.1001/jamainternmed.2026.0068
BibTeX
@article{Terplan2026,
author = {Terplan, Mishka and Lyerly, Anne D and Jones, Hendree},
title = {Extended-Release Buprenorphine During Pregnancy and the First Year After Birth—Protecting Pregnant People Through Ethical Research},
journal = {JAMA Internal Medicine},
year = {2026},
volume = {186},
number = {5},
pages = {544},
doi = {10.1001/jamainternmed.2026.0068}
}
EUVIMED